Phase III trial results establish chemotherapy plus letrozole as the new standard treatment for advanced low-grade serous ovarian and peritoneal carcinoma.
← News
Chemotherapy followed by letrozole sets standard for advanced, low-grade serous gynecologic carcinoma
Phase III Trial phase
Low-Grade Serous Ovarian/Peritoneal Carcinoma Cancer type
Stage II-IV Disease stage
Chemotherapy + Letrozole Winning treatment